REPLReplimune Group, Inc.Oct 28, 2026Q2 2027
Read transcript →Replimune Group, Inc. (REPL) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$21.86
—
Mkt Cap $1.96B
REPLReplimune Group, Inc.Oct 28, 2026REPLReplimune Group, Inc.May 22, 2025Q4 2025
Read transcript →